Zymergen Inc. (ZY)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Zymergen Inc. (ZY) with AI Score 56/100 (Hold). Zymergen Inc. specializes in the design, development, and commercialization of microbes, molecules, and materials, serving industries like electronics and agriculture. Market cap: 0, Sector: Basic materials.
Last analyzed: Mar 17, 2026Zymergen Inc. (ZY) Materials & Commodity Exposure
Zymergen Inc., a subsidiary of Ginkgo Bioworks, focuses on developing and commercializing innovative microbes, molecules, and materials. The company serves diverse sectors, including electronics, packaging, and agriculture, utilizing automation solutions to enhance its research and development processes within the specialty chemicals industry.
Investment Thesis
Zymergen Inc., now a subsidiary of Ginkgo Bioworks, presents a unique investment proposition within the specialty chemicals sector. While its standalone financials, such as a negative profit margin of -2160.8% and a gross margin of -316.4%, indicate past challenges, the integration with Ginkgo provides potential synergies and access to advanced resources. Key value drivers include Zymergen's expertise in microbial engineering and automation, which can enhance Ginkgo's overall capabilities. Growth catalysts involve leveraging Ginkgo's platform to accelerate product development and commercialization. However, potential risks include integration challenges and the need to demonstrate tangible financial improvements post-acquisition. Investors should monitor the combined entity's ability to generate revenue and achieve profitability in the long term.
Based on FMP financials and quantitative analysis
Key Highlights
- Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc. since October 19, 2022.
- The company specializes in designing, developing, and commercializing microbes, molecules, and materials.
- Zymergen serves diverse industries, including electronics, packaging, healthcare, and agriculture.
- The company offers an automation solution comprising reconfigurable automation carts and cloud-based control software.
- Zymergen's financial performance shows a negative profit margin of -2160.8% and a gross margin of -316.4%.
Competitors & Peers
Strengths
- Innovative microbial engineering platform
- Expertise in automation solutions for R&D
- Access to Ginkgo Bioworks' resources and expertise
- Potential for developing sustainable materials
Weaknesses
- Negative profit and gross margins
- Reliance on Ginkgo Bioworks for resources
- Challenges in scaling operations and commercializing products
- Limited brand recognition as a subsidiary
Catalysts
- Integration with Ginkgo Bioworks to leverage synergies and resources.
- Potential product launches in sustainable materials and agriculture sectors.
- Development of advanced automation solutions for R&D labs.
- Expansion into high-performance materials for electronics.
Risks
- Integration challenges with Ginkgo Bioworks.
- Competition from established chemical companies.
- Regulatory hurdles for bio-based products.
- Economic downturn affecting R&D spending.
Growth Opportunities
- Leveraging Ginkgo Bioworks' Platform: Zymergen can leverage Ginkgo Bioworks' extensive platform and resources to accelerate its research and development efforts. This includes access to Ginkgo's vast library of biological components, advanced automation capabilities, and expertise in strain engineering. By integrating its capabilities with Ginkgo's platform, Zymergen can potentially develop and commercialize new products more efficiently, targeting a larger share of the specialty chemicals market. This synergy can drive growth and enhance Zymergen's competitive position within the industry, with potential revenue impacts visible within the next 2-3 years.
- Expanding into Sustainable Materials: The increasing demand for sustainable and bio-based materials presents a significant growth opportunity for Zymergen. By focusing on developing eco-friendly alternatives to traditional chemicals and materials, Zymergen can cater to environmentally conscious consumers and industries. This includes developing biodegradable polymers, bio-based adhesives, and sustainable coatings. The market for sustainable materials is projected to grow significantly in the coming years, driven by regulatory pressures and consumer preferences, offering Zymergen a substantial growth avenue. Expect to see initial market traction within the next 1-2 years.
- Penetrating the Agriculture Sector: Zymergen can expand its presence in the agriculture sector by developing microbial solutions for crop protection and yield enhancement. This includes developing bio-based pesticides, fertilizers, and soil amendments that improve crop health and productivity. The agriculture sector is increasingly adopting sustainable practices, creating a demand for innovative microbial solutions. Zymergen's expertise in microbial engineering positions it to develop effective and environmentally friendly products for this market, potentially leading to increased revenue and market share. This expansion could yield results in the next 3-5 years.
- Developing Advanced Automation Solutions: Zymergen can further develop and commercialize its automation solutions for research and development labs. This includes offering customized automation systems, modular hardware building blocks, and cloud-based control software. The demand for automation in labs is growing, driven by the need for increased efficiency, accuracy, and throughput. By providing advanced automation solutions, Zymergen can cater to this demand and generate revenue from both product sales and service offerings. This growth opportunity can be realized within the next 2 years.
- Creating High-Performance Materials for Electronics: Zymergen can focus on developing high-performance materials for the electronics industry, such as advanced polymers, adhesives, and coatings. These materials can be used in various electronic devices, including smartphones, tablets, and computers. The electronics industry is constantly seeking innovative materials with enhanced properties, creating a demand for Zymergen's expertise. By developing specialized materials for this sector, Zymergen can capture a share of the high-value electronics market, with potential revenue streams emerging in the next 3-4 years.
Opportunities
- Expanding into sustainable materials market
- Penetrating the agriculture sector with microbial solutions
- Developing advanced automation solutions for labs
- Creating high-performance materials for electronics
Threats
- Competition from established chemical companies
- Regulatory hurdles for bio-based products
- Economic downturn affecting R&D spending
- Technological disruptions in the materials science field
Competitive Advantages
- Proprietary microbial engineering platform
- Expertise in automation solutions
- Access to Ginkgo Bioworks' resources
- Specialized knowledge in material science
About ZY
Zymergen Inc., established in 2013 and based in Emeryville, California, is a company focused on designing, developing, and commercializing microbes, molecules, and materials. Its core business revolves around creating innovative solutions for various industries, including electronics, packaging, healthcare, and agriculture. Zymergen provides an automation solution that includes reconfigurable automation carts, modular hardware building blocks for customized lab work cells, and cloud-based automation control software. This integrated approach enables efficient and tailored automation systems for its clients. Zymergen's founding vision was to leverage synthetic biology and automation to create novel materials and chemicals with enhanced properties and functionalities. The company aimed to disrupt traditional manufacturing processes by offering sustainable and high-performance alternatives. However, Zymergen faced challenges in scaling its operations and commercializing its products, leading to its acquisition by Ginkgo Bioworks Holdings, Inc. in October 2022. As a subsidiary of Ginkgo Bioworks, Zymergen continues to operate, focusing on its core competencies in microbial engineering and automation. The acquisition has provided Zymergen with access to Ginkgo's broader platform and resources, potentially accelerating its research and development efforts. The company's commitment to serving diverse industries remains unchanged, as it strives to deliver innovative and sustainable solutions to meet evolving market demands.
What They Do
- Designs and develops microbes, molecules, and materials.
- Commercializes its developed products for various industries.
- Offers automation solutions for research and development labs.
- Provides reconfigurable automation carts for customized lab setups.
- Develops modular hardware building blocks for work cell assembly.
- Offers cloud-based software to control integrated automation systems.
Business Model
- Develops and sells microbes, molecules, and materials.
- Provides automation solutions to research labs.
- Generates revenue through product sales and service offerings.
Industry Context
Zymergen Inc. operates within the specialty chemicals industry, a sector characterized by high innovation and customized solutions. The industry is driven by the demand for advanced materials and chemicals with specific properties, catering to diverse applications across various sectors. Key trends include the increasing adoption of sustainable and bio-based materials, driven by environmental concerns and regulatory pressures. The competitive landscape includes established chemical companies and emerging biotech firms. Zymergen's focus on microbial engineering and automation positions it to capitalize on the growing demand for sustainable and high-performance materials, particularly within Ginkgo Bioworks' broader ecosystem.
Key Customers
- Electronics manufacturers
- Packaging companies
- Healthcare providers
- Agricultural businesses
Financials
Chart & Info
Zymergen Inc. (ZY) stock price: Price data unavailable
Latest News
No recent news available for ZY.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ZY.
Price Targets
Wall Street price target analysis for ZY.
MoonshotScore
What does this score mean?
The MoonshotScore rates ZY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Leadership: Joshua J. Hoffmann
CEO
Joshua J. Hoffmann serves as the CEO of Zymergen Inc. His background includes extensive experience in managing and leading technology-driven companies. He has a proven track record in driving innovation and commercializing new products. Hoffmann's expertise spans various industries, including biotechnology, materials science, and automation. He is known for his strategic vision and ability to build high-performing teams. His leadership is focused on leveraging Zymergen's core competencies to create value for its stakeholders.
Track Record: Under Joshua J. Hoffmann's leadership, Zymergen has focused on developing and commercializing innovative microbes, molecules, and materials. He has overseen the company's efforts to provide automation solutions for research and development labs. Key milestones include expanding Zymergen's presence in diverse industries and integrating its capabilities with Ginkgo Bioworks. His strategic decisions have aimed to enhance Zymergen's competitive position and drive long-term growth.
What Investors Ask About Zymergen Inc. (ZY) — Basic Materials
What does Zymergen Inc. do?
Zymergen Inc. specializes in the design, development, and commercialization of microbes, molecules, and materials. The company provides innovative solutions for various industries, including electronics, packaging, healthcare, and agriculture. Zymergen offers automation solutions for research and development labs, including reconfigurable automation carts and cloud-based control software. As a subsidiary of Ginkgo Bioworks, Zymergen leverages its expertise in microbial engineering and automation to create value for its stakeholders.
What do analysts say about ZY stock?
As Zymergen Inc. is now a subsidiary of Ginkgo Bioworks (ticker: DNA), standalone analyst ratings for ZY are no longer applicable. Investors should focus on the performance and prospects of Ginkgo Bioworks, considering Zymergen's contribution to the combined entity. Key valuation metrics for Ginkgo Bioworks include revenue growth, gross margin, and cash flow. Growth considerations involve the company's ability to commercialize new products and expand its market share in the synthetic biology sector. Investors should monitor Ginkgo's financial performance and strategic initiatives to assess the potential impact of the Zymergen acquisition.
What are the main risks for ZY?
The main risks for Zymergen Inc. as a subsidiary of Ginkgo Bioworks include integration challenges, competition from established chemical companies, and regulatory hurdles for bio-based products. Integration risks involve the potential for disruptions and inefficiencies during the merging of Zymergen's operations with Ginkgo's platform. Competition from larger chemical companies with greater resources and market share poses a threat to Zymergen's growth prospects. Regulatory challenges may arise from the need to comply with environmental and safety regulations for bio-based products, potentially increasing costs and delaying product launches. Economic downturns can also affect R&D spending and demand for Zymergen's products.
What are the key factors to evaluate for ZY?
Zymergen Inc. (ZY) currently holds an AI score of 56/100, indicating moderate score. Key strength: Innovative microbial engineering platform. Primary risk to monitor: Integration challenges with Ginkgo Bioworks. This is not financial advice.
How frequently does ZY data refresh on this page?
ZY prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ZY's recent stock price performance?
Recent price movement in Zymergen Inc. (ZY) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative microbial engineering platform. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ZY overvalued or undervalued right now?
Determining whether Zymergen Inc. (ZY) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ZY?
Before investing in Zymergen Inc. (ZY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial data may not reflect the most recent performance.